PT2095822E - Péptidos de epítopo derivados de receptor de factor de crescimento endotelial vascular 1 e vacinas contendo estes péptidos - Google Patents
Péptidos de epítopo derivados de receptor de factor de crescimento endotelial vascular 1 e vacinas contendo estes péptidosInfo
- Publication number
- PT2095822E PT2095822E PT90075490T PT09007549T PT2095822E PT 2095822 E PT2095822 E PT 2095822E PT 90075490 T PT90075490 T PT 90075490T PT 09007549 T PT09007549 T PT 09007549T PT 2095822 E PT2095822 E PT 2095822E
- Authority
- PT
- Portugal
- Prior art keywords
- peptides
- growth factor
- vascular endothelial
- factor receptor
- endothelial growth
- Prior art date
Links
- 102000004196 processed proteins & peptides Human genes 0.000 title abstract 6
- 108090000765 processed proteins & peptides Proteins 0.000 title abstract 6
- 229960005486 vaccine Drugs 0.000 title abstract 2
- 102000016548 Vascular Endothelial Growth Factor Receptor-1 Human genes 0.000 title 1
- 108010053096 Vascular Endothelial Growth Factor Receptor-1 Proteins 0.000 title 1
- 125000003275 alpha amino acid group Chemical group 0.000 abstract 2
- 206010028980 Neoplasm Diseases 0.000 abstract 1
- 150000001413 amino acids Chemical class 0.000 abstract 1
- 210000001151 cytotoxic T lymphocyte Anatomy 0.000 abstract 1
- 229940079593 drug Drugs 0.000 abstract 1
- 239000003814 drug Substances 0.000 abstract 1
- 230000002163 immunogen Effects 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
- C07K14/71—Receptors; Cell surface antigens; Cell surface determinants for growth factors; for growth regulators
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/06—Antipsoriatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A61P35/04—Antineoplastic agents specific for metastasis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/04—Immunostimulants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Organic Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Immunology (AREA)
- Diabetes (AREA)
- Microbiology (AREA)
- Mycology (AREA)
- Epidemiology (AREA)
- Biochemistry (AREA)
- Molecular Biology (AREA)
- Cardiology (AREA)
- Heart & Thoracic Surgery (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Genetics & Genomics (AREA)
- Biophysics (AREA)
- Gastroenterology & Hepatology (AREA)
- Rheumatology (AREA)
- Zoology (AREA)
- Toxicology (AREA)
- Cell Biology (AREA)
- Urology & Nephrology (AREA)
- Vascular Medicine (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Pain & Pain Management (AREA)
- Dermatology (AREA)
- Ophthalmology & Optometry (AREA)
- Physical Education & Sports Medicine (AREA)
- Obesity (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US65752705P | 2005-02-28 | 2005-02-28 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| PT2095822E true PT2095822E (pt) | 2013-12-09 |
Family
ID=36581423
Family Applications (3)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PT101779601T PT2289533E (pt) | 2005-02-28 | 2006-02-17 | Péptidos de epítopo derivados de receptor de factor de crescimento endotelial vascular 1 e vacinas contendo estes péptidos |
| PT90075490T PT2095822E (pt) | 2005-02-28 | 2006-02-17 | Péptidos de epítopo derivados de receptor de factor de crescimento endotelial vascular 1 e vacinas contendo estes péptidos |
| PT06714491T PT1855707E (pt) | 2005-02-28 | 2006-02-17 | Péptidos de epítopo derivados de receptor de factor de crescimento endotelial vascular 1 e vacinas contendo estes péptidos |
Family Applications Before (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PT101779601T PT2289533E (pt) | 2005-02-28 | 2006-02-17 | Péptidos de epítopo derivados de receptor de factor de crescimento endotelial vascular 1 e vacinas contendo estes péptidos |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PT06714491T PT1855707E (pt) | 2005-02-28 | 2006-02-17 | Péptidos de epítopo derivados de receptor de factor de crescimento endotelial vascular 1 e vacinas contendo estes péptidos |
Country Status (11)
| Country | Link |
|---|---|
| US (4) | US7919099B2 (pt) |
| EP (4) | EP2095822B1 (pt) |
| JP (3) | JP4931154B2 (pt) |
| CY (1) | CY1112867T1 (pt) |
| DK (3) | DK1855707T3 (pt) |
| ES (3) | ES2442294T3 (pt) |
| HK (3) | HK1152873A1 (pt) |
| PL (3) | PL1855707T3 (pt) |
| PT (3) | PT2289533E (pt) |
| SI (3) | SI2095822T1 (pt) |
| WO (1) | WO2006093030A1 (pt) |
Families Citing this family (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP2270042B1 (en) | 2002-09-12 | 2015-01-14 | Oncotherapy Science, Inc. | KDR peptides and vaccines comprising the same |
| CN103784938A (zh) * | 2007-02-16 | 2014-05-14 | 肿瘤疗法科学股份有限公司 | 脉络膜血管新生的疫苗疗法 |
| TW201109029A (en) * | 2009-06-11 | 2011-03-16 | Oncotherapy Science Inc | Vaccine therapy for choroidal neovascularization |
| WO2013133405A1 (ja) | 2012-03-09 | 2013-09-12 | オンコセラピー・サイエンス株式会社 | ペプチドを含む医薬組成物 |
| US9840553B2 (en) | 2014-06-28 | 2017-12-12 | Kodiak Sciences Inc. | Dual PDGF/VEGF antagonists |
| AU2016381964B2 (en) | 2015-12-30 | 2024-02-15 | Kodiak Sciences Inc. | Antibodies and conjugates thereof |
| CN110612115A (zh) * | 2017-05-19 | 2019-12-24 | 学校法人庆应义塾 | 针对脑神经疾病的肽疫苗和肽疫苗组合物 |
| CN112203679A (zh) | 2018-03-02 | 2021-01-08 | 科达制药股份有限公司 | Il-6抗体及其融合构建体和缀合物 |
| CN114786731A (zh) | 2019-10-10 | 2022-07-22 | 科达制药股份有限公司 | 治疗眼部病症的方法 |
Family Cites Families (25)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4722848A (en) | 1982-12-08 | 1988-02-02 | Health Research, Incorporated | Method for immunizing animals with synthetically modified vaccinia virus |
| US5703055A (en) | 1989-03-21 | 1997-12-30 | Wisconsin Alumni Research Foundation | Generation of antibodies through lipid mediated DNA delivery |
| JPH0418667A (ja) * | 1989-07-05 | 1992-01-22 | Tohoku Nippon Denki Software Kk | 自動配送システム |
| JPH0350140A (ja) * | 1989-07-18 | 1991-03-04 | Seiko Epson Corp | 分布屈折率レンズの製造方法 |
| CA2158745C (en) | 1993-03-25 | 2007-06-19 | Richard L. Kendall | Inhibitor of vascular endothelial cell growth factor |
| US5804566A (en) | 1993-08-26 | 1998-09-08 | The Regents Of The University Of California | Methods and devices for immunizing a host through administration of naked polynucleotides with encode allergenic peptides |
| US5679647A (en) | 1993-08-26 | 1997-10-21 | The Regents Of The University Of California | Methods and devices for immunizing a host against tumor-associated antigens through administration of naked polynucleotides which encode tumor-associated antigenic peptides |
| US5739118A (en) | 1994-04-01 | 1998-04-14 | Apollon, Inc. | Compositions and methods for delivery of genetic material |
| US5736524A (en) | 1994-11-14 | 1998-04-07 | Merck & Co.,. Inc. | Polynucleotide tuberculosis vaccine |
| US5922687A (en) | 1995-05-04 | 1999-07-13 | Board Of Trustees Of The Leland Stanford Junior University | Intracellular delivery of nucleic acids using pressure |
| ATE319477T1 (de) | 1995-08-03 | 2006-03-15 | Univ Leiden | Antigen presentierende bläschen, die von zellen ableiten |
| US5853719A (en) | 1996-04-30 | 1998-12-29 | Duke University | Methods for treating cancers and pathogen infections using antigen-presenting cells loaded with RNA |
| US6100071A (en) | 1996-05-07 | 2000-08-08 | Genentech, Inc. | Receptors as novel inhibitors of vascular endothelial growth factor activity and processes for their production |
| CA2262006A1 (en) | 1996-07-26 | 1998-02-05 | Sloan-Kettering Institute For Cancer Research | Method and reagents for genetic immunization |
| FR2766205B1 (fr) | 1997-07-16 | 2002-08-30 | Inst Nat Sante Rech Med | Nouveau procede de sensibilisation de cellules presentatrices d'antigene et nouveaux moyens pour la mise en oeuvre du procede |
| US6200954B1 (en) * | 1998-09-04 | 2001-03-13 | National University Of Singapore | Small peptides having potent anti-angiogenic activity |
| AU2002257647A1 (en) * | 2001-03-09 | 2002-09-24 | Callistogen Ag | Induction of anti-tumor cytotoxic t-lymphocytes in humans using peptide epitopes found by computer based algorithms for vaccination |
| FI110549B (fi) | 2001-06-29 | 2003-02-14 | Nokia Corp | Menetelmä ja järjestely liikkeen määrittämiseksi |
| US20030157101A1 (en) * | 2001-11-15 | 2003-08-21 | Carlo Gambacorti-Passerini | Immunogenic ALK peptides |
| WO2003050140A1 (fr) | 2001-12-10 | 2003-06-19 | Kyogo Itoh | Antigenes tumoraux |
| CU23178A1 (es) | 2002-04-15 | 2006-09-22 | Ct Ingenieria Genetica Biotech | INMUNOTERAPIA ACTIVA ANTIANGIOGéNICA |
| JP2004018667A (ja) | 2002-06-17 | 2004-01-22 | National Institute Of Advanced Industrial & Technology | 高分子化合物膜の表面における炭酸カルシウム被膜の製造方法 |
| JP4406607B2 (ja) | 2002-08-26 | 2010-02-03 | オンコセラピー・サイエンス株式会社 | ペプチド及びこれを含む医薬 |
| EP2270042B1 (en) * | 2002-09-12 | 2015-01-14 | Oncotherapy Science, Inc. | KDR peptides and vaccines comprising the same |
| TW201109029A (en) | 2009-06-11 | 2011-03-16 | Oncotherapy Science Inc | Vaccine therapy for choroidal neovascularization |
-
2006
- 2006-02-17 ES ES09007549.0T patent/ES2442294T3/es active Active
- 2006-02-17 EP EP09007549.0A patent/EP2095822B1/en not_active Not-in-force
- 2006-02-17 PL PL06714491T patent/PL1855707T3/pl unknown
- 2006-02-17 EP EP10177956A patent/EP2289532A1/en not_active Withdrawn
- 2006-02-17 PL PL09007549T patent/PL2095822T3/pl unknown
- 2006-02-17 ES ES10177960T patent/ES2435650T3/es active Active
- 2006-02-17 SI SI200631689T patent/SI2095822T1/sl unknown
- 2006-02-17 DK DK06714491.5T patent/DK1855707T3/da active
- 2006-02-17 PT PT101779601T patent/PT2289533E/pt unknown
- 2006-02-17 EP EP10177960.1A patent/EP2289533B1/en active Active
- 2006-02-17 PT PT90075490T patent/PT2095822E/pt unknown
- 2006-02-17 EP EP06714491A patent/EP1855707B1/en not_active Not-in-force
- 2006-02-17 SI SI200631350T patent/SI1855707T1/sl unknown
- 2006-02-17 DK DK10177960.1T patent/DK2289533T3/da active
- 2006-02-17 PT PT06714491T patent/PT1855707E/pt unknown
- 2006-02-17 ES ES06714491T patent/ES2385396T3/es active Active
- 2006-02-17 SI SI200631668T patent/SI2289533T1/sl unknown
- 2006-02-17 WO PCT/JP2006/303352 patent/WO2006093030A1/en active Application Filing
- 2006-02-17 US US11/816,893 patent/US7919099B2/en active Active
- 2006-02-17 JP JP2007529685A patent/JP4931154B2/ja not_active Expired - Fee Related
- 2006-02-17 PL PL10177960T patent/PL2289533T3/pl unknown
- 2006-02-17 DK DK09007549.0T patent/DK2095822T3/da active
-
2008
- 2008-05-06 HK HK11106949.6A patent/HK1152873A1/xx not_active IP Right Cessation
- 2008-05-06 HK HK08105026.9A patent/HK1110529A1/xx not_active IP Right Cessation
- 2008-05-06 HK HK10101587.5A patent/HK1133601A1/xx not_active IP Right Cessation
-
2010
- 2010-06-04 JP JP2010129158A patent/JP4843095B2/ja active Active
-
2011
- 2011-03-03 US US13/040,177 patent/US8257711B2/en not_active Expired - Fee Related
- 2011-12-05 JP JP2011265649A patent/JP5789820B2/ja not_active Expired - Fee Related
-
2012
- 2012-06-12 CY CY20121100533T patent/CY1112867T1/el unknown
- 2012-08-03 US US13/566,933 patent/US8663647B2/en not_active Expired - Fee Related
-
2014
- 2014-01-21 US US14/160,436 patent/US20140186381A1/en not_active Abandoned
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| HK1134507A1 (en) | Peptide vaccines for cancers expressing tumor-associated antigens | |
| PT2289533E (pt) | Péptidos de epítopo derivados de receptor de factor de crescimento endotelial vascular 1 e vacinas contendo estes péptidos | |
| HK1124077A1 (en) | Kdr peptides and vaccines comprising the same | |
| WO2006090810A3 (en) | Peptide vaccines for lung cancers expressing ttk, urlc10 or koc1 polypeptides | |
| MX2009004147A (es) | Vacunas de peptido para canceres que expresan polipeptidos mphosph1 o depdc1. | |
| MX2009007261A (es) | Vacuna de peptido foxp3. | |
| MX2010005816A (es) | Epítopos de péptido de stat3. | |
| EP3219720A3 (en) | Wdrpuh epitope peptides and vaccines containing the same | |
| CY1114720T1 (el) | Πεπτιδια επιτοπων που προερχονται απο τον υποδοχεα 1 του αγγειακου ενδοθηλιακου αυξητικου παραγοντα και εμβολια περιεχοντας αυτα τα πεπτιδια |